Answers are grounded in this paper and cite their sources.
Objective Acute symptomatic seizures (ASyS) account for nearly half of new onset seizures, but evidence guiding management remains limited. We aimed to characterize international variation in ASyS management across common etiologies. Methods We conducted a cross‐sectional, vignette‐based survey through the International League Against Epilepsy national chapters (February to May 2025). Five etiology‐based vignettes assessed clinical and electrographic ASyS scenario after ischemic stroke, traumatic brain injury (TBI), meningitis, hyponatremia, and alcohol withdrawal. Respondents who managed neonatal seizures completed a neonatal stroke vignette. We assessed antiseizure medication (ASM) initiation, duration after clinical ASyS, and continuous electroencephalography (cEEG) use. Interrespondent variability was quantified by normalized Shannon entropy ( H′ ). Multivariable generalized estimating equations accounted for repeated responses. Results Among 963 respondents (92 countries), 62% recommended ASM initiation in clinical and 61% in electrographic ASyS scenarios. Overall ASM initiation variability was high ( H′ = .96), highest for alcohol withdrawal ( H′ = 1.0), followed by stroke ( H′ > .9), and consistently higher for electrographic than clinical ASyS. Etiology was the strongest driver of ASM initiation. Compared with stroke, ASM initiation odds were higher for TBI (odds ratio [OR] = 2.5, 95% confidence interval [CI] = 2.2–2.8) and meningitis (OR = 1.9, 95% CI = 1.7–2.2), and lower for hyponatremia (OR = .2, 95% CI = .2–.2) and alcohol withdrawal (OR = .5, 95% CI = .5–.6). Compared with Europe, initiation odds were higher in North America (OR = 2.7, 95% CI = 2.0–3.6), Asia‐Oceania (OR = 2.4, 95% CI = 2.0–3.0), and Latin America (OR = 2.0, 95% CI = 1.5–2.7), but not Africa. These differences persisted after accounting for country income. Compared with stroke, the mean ASM duration was 3.2 months shorter for hyponatremia and .6 months longer for TBI. Alcohol withdrawal durations were polarized (41% discontinued at discharge; 20% continued >12 months). cEEG use was markedly higher in North America than Europe (OR = 11.3, 95% CI = 7.8–16.5). Among 291 neonatal respondents, 75% continued ASM beyond discharge. Significance ASyS management varies markedly, reaching near‐maximal heterogeneity in several common scenarios. Although etiology drives decisions, geography and provider characteristics also influence care, underscoring an urgent need for randomized trials and international consensus guidance to harmonize care.
No takes yet. Share an insight, caveat, or question.
Punia et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: